Biosimilars for psoriasis: clinical studies to determine similarity
Biosimilars are drugs that are similar, but not identical, to originator biologics. Pre-clinical analytical studies are required to show similarity on a molecular and structural level, but efficacy and safety studies in humans are essential to ultimately determine biosimilarity. In this review writt...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , |
---|---|
Формат: | Revisão |
Язык: | английский |
Опубликовано: |
2016
|
Online-ссылка: | https://doi.org/10.1111/bjd.15067 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|